| Early detection of diabetic kidney disease by urinary proteomics and subsequent intervention with spironolactone to delay progression (PRIORITY): a prospective observational … N Tofte, M Lindhardt, K Adamova, SJL Bakker, J Beige, JWJ Beulens, ... The lancet Diabetes & endocrinology 8 (4), 301-312, 2020 | 214 | 2020 |
| Effect of mineralocorticoid receptor antagonists on proteinuria and progression of chronic kidney disease: a systematic review and meta-analysis G Currie, AHM Taylor, T Fujita, H Ohtsu, M Lindhardt, P Rossing, ... BMC nephrology 17, 1-14, 2016 | 190 | 2016 |
| Proteomic prediction and Renin angiotensin aldosterone system Inhibition prevention Of early diabetic nephRopathy in TYpe 2 diabetic patients with normoalbuminuria (PRIORITY … M Lindhardt, F Persson, G Currie, C Pontillo, J Beige, C Delles, ... BMJ open 6 (3), e010310, 2016 | 136 | 2016 |
| Multicentre prospective validation of a urinary peptidome-based classifier for the diagnosis of type 2 diabetic nephropathy J Siwy, JP Schanstra, A Argiles, SJL Bakker, J Beige, P Boucek, K Brand, ... Nephrology Dialysis Transplantation 29 (8), 1563-1570, 2014 | 131 | 2014 |
| Urinary proteomics predict onset of microalbuminuria in normoalbuminuric type 2 diabetic patients, a sub-study of the DIRECT-Protect 2 study M Lindhardt, F Persson, P Zürbig, A Stalmach, H Mischak, D De Zeeuw, ... Nephrology Dialysis Transplantation 32 (11), 1866-1873, 2017 | 103 | 2017 |
| Prediction of chronic kidney disease stage 3 by CKD273, a urinary proteomic biomarker C Pontillo, ZY Zhang, JP Schanstra, L Jacobs, P Zürbig, L Thijs, ... Kidney International Reports 2 (6), 1066-1075, 2017 | 90 | 2017 |
| Prevention of microalbuminuria using early intervention with renin-angiotensin system inhibitors in patients with type 2 diabetes: A systematic review F Persson, M Lindhardt, P Rossing, HH Parving Journal of the Renin-Angiotensin-Aldosterone System 17 (3), 1470320316652047, 2016 | 66 | 2016 |
| Predicting albuminuria response to spironolactone treatment with urinary proteomics in patients with type 2 diabetes and hypertension M Lindhardt, F Persson, C Oxlund, IA Jacobsen, P Zürbig, H Mischak, ... Nephrology Dialysis Transplantation 33 (2), 296-303, 2018 | 50 | 2018 |
| Urinary proteomics for prediction of mortality in patients with type 2 diabetes and microalbuminuria GE Currie, BJ von Scholten, S Mary, JL Flores Guerrero, M Lindhardt, ... Cardiovascular Diabetology 17, 1-8, 2018 | 47 | 2018 |
| Additive prognostic value of plasma N-terminal pro-brain natriuretic peptide and coronary artery calcification for cardiovascular events and mortality in asymptomatic patients … BJ von Scholten, H Reinhard, TW Hansen, M Lindhardt, CL Petersen, ... Cardiovascular diabetology 14, 1-10, 2015 | 47 | 2015 |
| Characteristics of high‐and low‐risk individuals in the PRIORITY study: urinary proteomics and mineralocorticoid receptor antagonism for prevention of diabetic nephropathy in … N Tofte, M Lindhardt, K Adamova, J Beige, JWJ Beulens, AL Birkenfeld, ... Diabetic Medicine 35 (10), 1375-1382, 2018 | 29 | 2018 |
| Pleiotropic effects of liraglutide treatment on renal risk factors in type 2 diabetes: Individual effects of treatment EH Zobel, BJ von Scholten, M Lindhardt, F Persson, TW Hansen, ... Journal of Diabetes and its Complications 31 (1), 162-168, 2017 | 23 | 2017 |
| Serum uric acid and progression of diabetic nephropathy in type 1 diabetes S Pilemann-Lyberg, M Lindhardt, F Persson, S Andersen, P Rossing Journal of Diabetes and its Complications 32 (5), 470-473, 2018 | 16 | 2018 |
| PRIORITY investigators. Early detection of diabetic kidney disease by urinary proteomics and subsequent intervention with spironolactone to delay progression (PRIORITY): a … N Tofte, M Lindhardt, K Adamova, SJL Bakker, J Beige, JWJ Beulens, ... Lancet Diabetes Endocrinol 8 (4), 301-312, 2020 | 13 | 2020 |
| Changes in diabetes distress among people with type 2 diabetes during a risk screening programme for diabetic kidney disease–longitudinal observations of the PRIORITY study LE Joensen, KP Madsen, M Frimodt-Møller, N Tofte, I Willaing, ... Journal of diabetes and its complications 34 (1), 107467, 2020 | 10 | 2020 |
| Substantial decrease of PFAS with anion exchange resin treatment–A clinical cross-over trial JJ Møller, AC Lyngberg, PEC Hammer, EM Flachs, OS Mortensen, ... Environment International 185, 108497, 2024 | 6 | 2024 |
| Cuff inflations do not affect night-time blood pressure: comparison of 24 h ambulatory blood pressure measured by a cuff and a tonometric device in type 2 diabetes EH Petersen, S Theilade, TW Hansen, MK Lindhardt, P Rossing Blood Pressure Monitoring 20 (6), 369-372, 2015 | 6 | 2015 |
| Help-seekers in an early detection of psychosis service: the non-cases L Lindhardt, M Lindhardt, UH Haahr, LH Hastrup, E Simonsen, ... Frontiers in Psychiatry 12, 778785, 2021 | 3 | 2021 |
| Mineralocorticoid receptor antagonist treatment in patients with renal insufficiency and the associated risk of hyperkalemia and death SH Møller, DH Kofod, M Schou, C Torp-Pedersen, G Gislason, N Carlson, ... Journal of Hypertension 42 (3), 564-571, 2024 | 2 | 2024 |
| Cardiac arrhythmia and hypoglycaemia in patients receiving haemodialysis with and without diabetes (the CADDY study): protocol for a Danish multicentre cohort study DH Kofod, SZ Diederichsen, T Bomholt, MØ Andersen, M Rix, Y Liem, ... BMJ open 13 (10), e077063, 2023 | 1 | 2023 |
Peter RossingSteno Diabetes Center在 dadlnet.dk 的电子邮件经过验证
